目的 评估两种治疗方法对儿童注意缺陷多动障碍(ADHD)的疗效。方法 将符合DSM-Ⅳ诊断标准的1~6年级小学生ADHD儿童随机分为两组,父母系统培训联合药物(盐酸托莫西汀胶囊)治疗即干预组30例,药物(盐酸托莫西汀胶囊)治疗即对照组30例。干预组由儿童保健专科医师及专科护师对儿童父母进行为期12周的系统培训;对照组不给予任何干预措施。干预前后使用韦氏儿童智力量表(WISC)、家长及教师评分量表SNAP-Ⅳ对两组患儿干预后疗效进行评估。结果 父母系统培训联合药物(盐酸托莫西汀胶囊)治疗,ADHD症状分级,家长及教师评分均有下降,智商(IQ)和学习能力均有提高,以上差异均有统计学意义(P<0.05)。结论 父母系统培训联合药物(盐酸托莫西汀胶囊)治疗能有效地改善儿童注意缺陷及多动症状,提高儿童学习能力,同时也促进了医患沟通和互动,改善了亲子关系,家长易于接受,值得推广。
Abstract
Objective To assess the efficacy of two differentMethods for treating children with attention deficit hyperactivity disorder (ADHD).Methods Sixty children from grade 1~6 who met the DSM-Ⅳ diagnostic criteria with ADHD were randomized to parent training combined with atomoxetine hydrochloride group (30 cases,the intervention group) and only atomoxetine hydrochloride treatment group (30 cases,the control group).Parents of the intervention group were given systematic training for twelve weeks by child care specialists and specialist nurses;The control group was not given this intervention.Before and after the treatment,Wechsler Intelligence Scale for Children (WISC) and Parents and Teachers Rating Scale (SNAP-Ⅳ) were used to evaluate the efficacy.Results In intervention group,ADHD symptom and SNAP-Ⅳ both decreased,intelligence quotient (IQ) scores and learning abilities improved,these differences were statistically significant (P<0.05).Conclusions Parent training combined with atomoxetine hydrochloride can effectively improve the symptoms and study abilities of the children with ADHD,meanwhile it can promote communication and interaction between doctors and patients,relationship between parents and children comes better.This method is also easily accepted by parents and deserves to generalized in clinical practice.
关键词
注意缺陷多动障碍 /
父母系统培训 /
药物治疗 /
儿童 /
疗效
Key words
attention deficit hyperactivity disorder /
parent training /
drug treatment /
children /
efficacy
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 沈晓明,金星明.发育和行为儿科学[M].南京:江苏科学技术出版社,2003:12.
[2] Brown RT,Amler RW,Freeman WS,et al.Treatment of attention-deficit/hyperactivity disorder:overview of the evidence[J].Pediatrics,2005,115(6):749-757.
[3] American Psychiatric Association.Diagnostic and statistical manual of mental disorders[M].Washington DC:American Psychiatric Association,1994.
[4] 沈晓明,金星明.发育和行为儿科学[M].南京:江苏科学技术出版社,2003:12.
[5] 吴紫娟.盐酸托莫西汀口服致口周皮炎1例[J].中国医院药学杂志,2009,29(14):1251-1252.
[6] Steele M,Weiss M,Swanson J,et al.A randomized,controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methyl-phenidate in attention deficit-hyperactivity disorder[J].Can J Clin Pharmacol,2006,13(1):e50-62.
[7] 邓毅,王玉凤,苏林雁,等.儿童注意缺陷多动障碍防治指南[M].北京:北京大学医学出版社,2007:90-99.
[8] 杜亚松,黄慧桃.专家解答多动症:心理科[M].上海:上海科学技术文献出版社,2005:105-110.
[9] 张丽珊,金星明,章依文,等.父母小组培训对注意缺陷多动障碍儿童家庭干预的研究[J].中国儿童保健杂志,2009,17(5):539-540.
[10] 夏经炜,周婷婷,曹丽娟,等.儿童注意缺陷多动障碍医教结合干预研究初探[J].中国妇幼保健,2013,28(14):2183.
PDF(429 KB)
